Abvc Biopharma (ABVC) Leases (2019 - 2025)
Abvc Biopharma (ABVC) has disclosed Leases for 7 consecutive years, with $1.9 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Leases rose 198.77% year-over-year to $1.9 million, compared with a TTM value of $1.9 million through Dec 2025, up 198.77%, and an annual FY2025 reading of $1.9 million, up 198.77% over the prior year.
- Leases was $1.9 million for Q4 2025 at Abvc Biopharma, up from $369135.0 in the prior quarter.
- Across five years, Leases topped out at $1.9 million in Q4 2025 and bottomed at $369135.0 in Q3 2025.
- Average Leases over 5 years is $1.1 million, with a median of $1.0 million recorded in 2023.
- The sharpest move saw Leases surged 327.16% in 2021, then plummeted 43.58% in 2024.
- Year by year, Leases stood at $1.5 million in 2021, then fell by 21.11% to $1.2 million in 2022, then crashed by 30.3% to $809283.0 in 2023, then fell by 20.87% to $640387.0 in 2024, then surged by 198.77% to $1.9 million in 2025.
- Business Quant data shows Leases for ABVC at $1.9 million in Q4 2025, $369135.0 in Q3 2025, and $459325.0 in Q2 2025.